{"slug":"semaglutide-chemo-neuropathy","verification":{"valid":true,"entries":2,"head":"8eecd9ae93ea4db3a53b4b630a4e536345ea9c902f855ef3a55cf6e6a5abac9c"},"energy":{"passes":2,"tokens_in":14478,"tokens_out":2861,"tokens_total":17339,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8eecd9ae93ea4db3a53b4b630a4e536345ea9c902f855ef3a55cf6e6a5abac9c"},"provenance":[{"ts":"2026-06-30T00:30:02.119Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semaglutide for Chemo Neuropathy\nSlug: semaglutide-chemo-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Chemotherapy-induced neuropathy (CIPN)\",\"condition_key\":\"chemo-neuropathy\",\"primary_peptide\":\"semaglutide\",\"peptides_in_scope\":[{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_title\":\"Why Semaglutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\",\"**What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\",\"**What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\",\"**Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacit","response":"{\n  \"slug\": \"semaglutide-chemo-neuropathy\",\n  \"title\": \"Semaglutide for Chemotherapy-Induced Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\\n\\nChemotherapy-induced peripheral neuropathy (CIPN) involves damage to peripheral nerves from certain cancer drugs. This leads to symptoms like numbness, tingling, burning pain, and loss of sensation, often in hands and feet. The damage can persist after treatment ends. No approved preventive treatments exist. Standard approaches focus on symptom management rather than nerve repair.\\n\\nDegeneration layers include direct neurotoxic effects on axons and myelin from chemotherapies like taxanes or platinums. Metabolic stress and inflammation can compound issues. In people with diabetes, risk rises (human meta-analysis, OR 1.60). Weight-related mechanical factors may add load on already stressed nerves, though CIPN is not primarily weight-driven.\\n\\n## Why Semaglutide might help you\\n\\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n3. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\\n4. **Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nIf excess body weight contributes to overall mechanical stress on nerves or joints already affected by CIPN, weight reduction via GLP-1 pathways could indirectly ease load. Each pound lost may reduce compressive forces, though the ~4 lb per 1 lb rule applies mainly to spine. This addresses a metabolic/repair-support layer, not direct nerve regeneration from chemo damage. No human data links semaglutide specifically to CIPN repair.\\n\\n## Why Gabapentin /","tokens_in":14478,"tokens_out":2861,"cost":0,"prev":"genesis","hash":"e032c2d9458ab87c5022c246a46b68aaec0aed67f326a41c07fcfa134c7fb64f"},{"ts":"2026-07-17T02:41:44.093Z","model":"owner","action":"voxel_divide","prompt":"","input":"semaglutide-chemo-neuropathy","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e032c2d9458ab87c5022c246a46b68aaec0aed67f326a41c07fcfa134c7fb64f","hash":"8eecd9ae93ea4db3a53b4b630a4e536345ea9c902f855ef3a55cf6e6a5abac9c"}]}